Status:
COMPLETED
Effect of Photobiomodulation for Patients With Xerostomia
Lead Sponsor:
Pia Lopez Jornet
Conditions:
Photobiomodulation
Low-Level Light Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyposalivation is a condition represented by a reduced salivary flow and may include symptoms such as mouth dryness (xerostomia), pain, loss of taste,dysphagia, and dysphonia, all of which greatly aff...
Detailed Description
Inclusion criteria -the inclusion criteria for participating in the study were: age over 18 years; continuous xerostomia for over three months; and/or altered sialometry findings at baseline (salivary...
Eligibility Criteria
Inclusion
- the inclusion criteria for participating in the study were: age over 18 years; continuous xerostomia for over three months; and/or altered sialometry findings at baseline (salivary flow \< 0.1 mL/min).
Exclusion
- The exclusion criteria were: xerostomia as secondary to radiotherapy; patients with decompensated systemic disorders or cognitive problems
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 26 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05336981
Start Date
January 1 2020
End Date
January 26 2022
Last Update
April 20 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lopez-Jornet Pia
Murcia, N/A = Not Applicable, Spain, 30008
2
Pia Lopez Jornet
Murcia, Spain, 30004